Search results
News Highlights: Top Company News of the Day - Friday at 3 PM ET
Morningstar· 2 days agoEli Lilly to Spend $5.3 Billion to Make More Mounjaro, Zepbound The outlay to expand an Indiana production site, combined with a previous $3.7 billion commitment, is the largest manufacturing ...
Swiss National Bank Sells 8,600 Shares of Cassava Sciences, Inc. (NASDAQ:SAVA)
ETF DAILY NEWS· 5 hours agoSwiss National Bank lessened its stake in shares of Cassava Sciences, Inc. (NASDAQ:SAVA – Free Report) by 9.9% in the 4th quarter, according to the company in its most recent ...
Rakovina Therapeutics Announces $1.5 million Non-Brokered Private Placement
Digital Journal· 3 days agoThe most promising lead candidates will be further validated in the Company's laboratories at the University of British Columbia. Rakovina Therapeutics intends to advance ...
London Drugs says it’s unwilling to pay ransom demanded by hackers
Houston Today· 4 days agoRetailer London Drugs says it is “unwilling and unable” to pay a multimillion-dollar ransom to...
Trade of the Day: Bet on a Cannabis Rally with Village Farms (VFF) Stock
InvestorPlace· 3 days agoMarijuana has been in the news recently amid the U.S. Department of Justice’s proposal to reschedule...
Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
Digital Journal· 5 days agoAlgernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development ...
Jump Financial LLC Takes $522,000 Position in Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH)
ETF DAILY NEWS· 4 days agoJump Financial LLC purchased a new position in shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Free Report) during the 4th quarter, according to the company in its ...
AstraZeneca aims for $80 billion in total revenue by 2030
Colorado Springs Gazette· 5 days agoThe Anglo-Swedish drugmaker had reported total revenue of $45.81 billion last year and earlier expected to launch at least 15 new medicines between 2023 and 2030. CEO Pascal Soriot has turned ...
London Drugs says it's unwilling to pay ransom demanded by hackers
MSN News· 4 days agoRICHMOND, B.C. — Retailer London Drugs says it is "unwilling and unable" to pay a...
Merck KGaA to buy gene therapy tools maker for $600M
BioPharma Dive via Yahoo Finance· 3 days agoAnd even fewer have the ability to build such manufacturing, especially when weighing the cost against the inherently risky nature of drug development....